Top

Published in:

01-06-2017 | Review Article

Current Status of Nephron-Sparing Surgery (NSS) in the Management of Renal Tumours

Authors: Vivek Venkatramani, Sanjaya Swain, Ramgopal Satyanarayana, Dipen J. Parekh

Published in: Indian Journal of Surgical Oncology | Issue 2/2017

Abstract

Nephron-sparing surgery has emerged as the surgical treatment of choice for small renal masses over the past two decades, replacing the traditional teaching of radical nephrectomy for renal cell carcinoma. With time, there has been an evolution in the techniques and indications for partial nephrectomy. This review summarizes the current status of nephron-sparing surgery for renal carcinoma and also deals with the future of this procedure.

Uzzo RG, Novick AC (2001) Nephron sparing surgery for renal tumors: indications, techniques and outcomes. J Urol 166(1):6–18PubMedCrossRef

Lam JS, Belldegrun AS, Pantuck AJ (2006) Long-term outcomes of the surgical management of renal cell carcinoma. World J Urol 24(3):255–266PubMedCrossRef

Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A et al (2005) Cancer statistics, 2005. CA Cancer J Clin 55(1):10–30PubMedCrossRef

Russo P (2010) Partial nephrectomy for renal cancer: part I. BJU Int 105(9):1206–1220PubMedCrossRef

Russo P (2013) Oncological and renal medical importance of kidney-sparing surgery. Nat Rev Urol. 10(5):292–299PubMedCrossRef

Licht MR, Novick AC (1993) Nephron sparing surgery for renal cell carcinoma. J Urol 149(1):1–7PubMedCrossRef

Russo P, Huang W (2008) The medical and oncological rationale for partial nephrectomy for the treatment of T1 renal cortical tumors. Urol Clin North Am. 35(4):635–643 viiPubMedCrossRef

Thompson RH, Kurta JM, Kaag M, Tickoo SK, Kundu S, Katz D et al (2009) Tumor size is associated with malignant potential in renal cell carcinoma cases. J Urol 181(5):2033–2036PubMedPubMedCentralCrossRef

Nguyen MM, Gill IS (2009) Effect of renal cancer size on the prevalence of metastasis at diagnosis and mortality. J Urol 181(3):1020–1027 discussion 1027PubMedCrossRef

10.

Fergany AF, Hafez KS, Novick AC (2000) Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup. J Urol 163(2):442–445PubMedCrossRef

11.

Timsit M-O, Bazin J-P, Thiounn N, Fontaine E, Chrétien Y, Dufour B et al (2006) Prospective study of safety margins in partial nephrectomy: intraoperative assessment and contribution of frozen section analysis. Urology 67(5):923–926PubMedCrossRef

12.

Yossepowitch O, Thompson RH, Leibovich BC, Eggener SE, Pettus JA, Kwon ED et al (2008) Positive surgical margins at partial nephrectomy: predictors and oncological outcomes. J Urol 179(6):2158–2163PubMedPubMedCentralCrossRef

13.

Van Poppel H, Becker F, Cadeddu JA, Gill IS, Janetschek G, Jewett MAS et al (2011) Treatment of localised renal cell carcinoma. Eur Urol 60(4):662–672PubMedCrossRef

14.

Kaplan C, Pasternack B, Shah H, Gallo G (1975) Age-related incidence of sclerotic glomeruli in human kidneys. Am J Pathol 80(2):227–234PubMedPubMedCentral

15.

Bijol V, Mendez GP, Hurwitz S, Rennke HG, Nosé V (2006) Evaluation of the nonneoplastic pathology in tumor nephrectomy specimens: predicting the risk of progressive renal failure. Am J Surg Pathol 30(5):575–584PubMedCrossRef

16.

Huang WC, Levey AS, Serio AM, Snyder M, Vickers AJ, Raj GV et al (2006) Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol 7(9):735–740PubMedPubMedCentralCrossRef

17.

Lau WK, Blute ML, Weaver AL, Torres VE, Zincke H (2000) Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. Mayo Clin Proc 75(12):1236–1242PubMedCrossRef

18.

McKiernan J, Simmons R, Katz J, Russo P (2002) Natural history of chronic renal insufficiency after partial and radical nephrectomy. Urology 59(6):816–820PubMedCrossRef

19.

Thompson RH, Boorjian SA, Lohse CM, Leibovich BC, Kwon ED, Cheville JC et al (2008) Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. J Urol 179(2):468–471 discussion 472–473PubMedCrossRef

20.

Pahernik S, Roos F, Röhrig B, Wiesner C, Thüroff JW (2008) Elective nephron sparing surgery for renal cell carcinoma larger than 4 cm. J Urol 179(1):71–74 discussion 74PubMedCrossRef

21.

Thompson RH, Siddiqui S, Lohse CM, Leibovich BC, Russo P, Blute ML (2009) Partial versus radical nephrectomy for 4 to 7 cm renal cortical tumors. J Urol 182(6):2601–2606PubMedPubMedCentralCrossRef

22.

Volpe A, Amparore D, Mottrie A (2013) Treatment outcomes of partial nephrectomy for T1b tumours. Curr Opin Urol 23(5):403–410PubMedCrossRef

23.

Touijer K, Jacqmin D, Kavoussi LR, Montorsi F, Patard JJ, Rogers CG et al (2010) The expanding role of partial nephrectomy: a critical analysis of indications, results, and complications. Eur Urol 57(2):214–222PubMedCrossRef

24.

Hansen J, Sun M, Bianchi M, Rink M, Tian Z, Hanna N et al (2012) Assessment of cancer control outcomes in patients with high-risk renal cell carcinoma treated with partial nephrectomy. Urology 80(2):347–353PubMedCrossRef

25.

Lee HJ, Liss MA, Derweesh IH (2014) Outcomes of partial nephrectomy for clinical T1b and T2 renal tumors. Curr Opin Urol 24(5):448–452PubMedCrossRef

26.

Kopp RP, Mehrazin R, Palazzi KL, Liss MA, Jabaji R, Mirheydar HS et al (2014) Survival outcomes after radical and partial nephrectomy for clinical T2 renal tumours categorised by R.E.N.A.L. nephrometry score. BJU Int 114(5):708–718PubMedCrossRef

27.

Bex A, Kroon BK, de Bruijn R (2012) Is there a role for neoadjuvant targeted therapy to downsize primary tumors for organ sparing strategies in renal cell carcinoma? Int J Surg Oncol 2012:250479PubMedPubMedCentral

28.

Cost NG, Krabbe L-M, Bagrodia A, Margulis V (2013) The use of preoperative targeted molecular therapy to allow nephron sparing for T1b tumors. Curr Opin Urol 23(5):411–417PubMedCrossRef

29.

Shahait M, Mukherji D, El-Hout Y (2015) Partial nephrectomy for metastatic renal cell carcinoma: where do we stand? Indian J Urol IJU J Urol Soc India 31(2):102–105CrossRef

30.

Rini BI, Plimack ER, Takagi T, Elson P, Wood LS, Dreicer R et al (2015) A phase II study of pazopanib in patients with localized renal cell carcinoma to optimize preservation of renal parenchyma. J Urol 194(2):297–303PubMedCrossRef

31.

Buethe DD, Spiess PE (2013) Current management considerations for the incidentally detected small renal mass. Cancer Control J Moffitt Cancer Cent 20(3):211–221

32.

Waldert M, Klatte T (2014) Nephrometry scoring systems for surgical decision-making in nephron-sparing surgery. Curr Opin Urol 24(5):437–440PubMedCrossRef

33.

Kutikov A, Uzzo RG (2009) The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol 182(3):844–853PubMedCrossRef

34.

Russo P (2010) Partial nephrectomy for renal cancer (part II): the impact of renal ischaemia, patient preparation, surgical approaches, management of complications and utilization. BJU Int 105(11):1494–1507PubMedCrossRef

35.

Parekh DJ, Weinberg JM, Ercole B, Torkko KC, Hilton W, Bennett M et al (2013) Tolerance of the human kidney to isolated controlled ischemia. J Am Soc Nephrol JASN 24(3):506–517PubMedCrossRef

36.

Wszolek MF, Kenney PA, Libertino JA (2011) Nonclamping partial nephrectomy: towards improved nephron sparing. Nat Rev Urol. 8(9):523–527PubMedCrossRef

37.

Kallingal GJS, Weinberg JM, Reis IM, Nehra A, Venkatachalam MA, Parekh DJ (2015) Long-term response to renal ischaemia in the human kidney after partial nephrectomy: results from a prospective clinical trial. BJU Int

38.

Hung AJ, Tsai S, Gill IS (2013) Does eliminating global renal ischemia during partial nephrectomy improve functional outcomes? Curr Opin Urol 23(2):112–117PubMedCrossRef

39.

Lane BR, Novick AC (2007) Nephron-sparing surgery. BJU Int 99(5 Pt B):1245–1250PubMedCrossRef

40.

Eisenberg MS, Patil MB, Thangathurai D, Gill IS (2011) Innovations in laparoscopic and robotic partial nephrectomy: a novel “zero ischemia” technique. Curr Opin Urol 21(2):93–98PubMedCrossRef

41.

Simone G, Ferriero M, Papalia R, Costantini M, Guaglianone S, Gallucci M (2013) Zero-ischemia minimally invasive partial nephrectomy. Curr Urol Rep 14(5):465–470PubMedCrossRef

42.

Autorino R, Zargar H, White WM, Novara G, Annino F, Perdonà S et al (2014) Current applications of near-infrared fluorescence imaging in robotic urologic surgery: a systematic review and critical analysis of the literature. Urology 84(4):751–759PubMedCrossRef

43.

Krane LS, Hemal AK (2014) Emerging technologies to improve techniques and outcomes of robotic partial nephrectomy: striving toward the pentafecta. Urol Clin North Am. 41(4):511–519PubMedCrossRef

44.

Leslie S, Goh AC, Gill IS (2013) Partial nephrectomy—contemporary indications, techniques and outcomes. Nat Rev Urol 10(5):275–283PubMedCrossRef

45.

Ficarra V, Rossanese M, Gnech M, Novara G, Mottrie A (2014) Outcomes and limitations of laparoscopic and robotic partial nephrectomy. Curr Opin Urol 24(5):441–447PubMedCrossRef

46.

Rogers C, Sukumar S, Gill IS (2011) Robotic partial nephrectomy: the real benefit. Curr Opin Urol 21(1):60–64PubMedCrossRef

47.

Sivarajan G, Huang WC (2012) Current practice patterns in the surgical management of renal cancer in the United States. Urol Clin North Am 39(2):149–160 vPubMedCrossRef

Title: Current Status of Nephron-Sparing Surgery (NSS) in the Management of Renal Tumours
Authors: Vivek Venkatramani
Sanjaya Swain
Ramgopal Satyanarayana
Dipen J. Parekh
Publication date: 01-06-2017
Publisher: Springer India
Published in: Indian Journal of Surgical Oncology / Issue 2/2017
Print ISSN: 0975-7651
Electronic ISSN: 0976-6952
DOI: https://doi.org/10.1007/s13193-016-0587-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Current Status of Nephron-Sparing Surgery (NSS) in the Management of Renal Tumours

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2017

Rare Case Report of Alveolar Soft Part Sarcoma of the Orbit

Feasibility of Axillary Reverse Mapping and Clinicopathological Features Predicting ARM Node Metastasis in Breast Cancer—a Pilot Study

Epithelio- Myoepithelial Carcinoma of Masseteric Space: a Case Report

Advanced Primary Epithelial Ovarian and Peritoneal Carcinoma—Does Diagnostic Accuracy of Preoperative CT Scan for Detection of Peritoneal Metastatic Sites Reflect into Prediction of Suboptimal Debulking? A Prospective Study

Nodular Fasciitis in the Tongue—a Mimicker of Malignancy: Case Report and Review of Literature

Unilateral Exploration for Parathyroid Adenoma